Who Benefits from 340B? Empowering Patients Over Institutions

In this episode of Healthcare Americana, host Christopher Habig is joined by Dr. Anthony DiGiorgio. Together, they explore the 340B Drug Discount Program, a federal initiative meant to help low-income patients access affordable medications. They reveal how the program has shifted over time to prioritize large healthcare institutions, creating unintended consequences like inflated healthcare costs and reduced patient access to discounts. The conversation calls for greater transparency and reforms to ensure the program supports those it was designed for. By addressing these challenges and realigning the program with its original mission, the healthcare system can better serve patients and create a more equitable and efficient model of care.More on Freedom Healthworks & FreedomDocSubscribe at https://healthcareamericana.com/More on Dr. Anthony DiGiorgioFollow Healthcare Americana: Instagram & LinkedIN